Bavarian Nordic A/S (BVNKF)
21.20
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Bavarian Nordic Shareholders Equity (Quarterly): 1.472B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.472B |
December 31, 2023 | 1.535B |
September 30, 2023 | 1.322B |
June 30, 2023 | 1.413B |
March 31, 2023 | 1.335B |
December 31, 2022 | 1.029B |
September 30, 2022 | 919.63M |
June 30, 2022 | 965.81M |
March 31, 2022 | 1.069B |
December 31, 2021 | 1.123B |
September 30, 2021 | 900.30M |
June 30, 2021 | 926.35M |
March 31, 2021 | 933.22M |
December 31, 2020 | 808.96M |
September 30, 2020 | 830.01M |
June 30, 2020 | 792.16M |
March 31, 2020 | 754.76M |
December 31, 2019 | 279.67M |
September 30, 2019 | 277.27M |
June 30, 2019 | 302.64M |
March 31, 2019 | 313.66M |
December 31, 2018 | 334.05M |
September 30, 2018 | 354.52M |
June 30, 2018 | 348.99M |
March 31, 2018 | 385.70M |
Date | Value |
---|---|
December 31, 2017 | 403.89M |
September 30, 2017 | 417.45M |
June 30, 2017 | 326.52M |
March 31, 2017 | 293.01M |
December 31, 2016 | 286.87M |
September 30, 2016 | 288.15M |
June 30, 2016 | 269.81M |
March 31, 2016 | 184.34M |
December 31, 2015 | 196.65M |
September 30, 2015 | 196.49M |
June 30, 2015 | 202.77M |
March 31, 2015 | 183.95M |
December 31, 2014 | 204.43M |
September 30, 2014 | 150.26M |
June 30, 2014 | 169.23M |
March 31, 2014 | 180.21M |
December 31, 2013 | 180.70M |
September 30, 2013 | 180.31M |
June 30, 2013 | 168.81M |
March 31, 2013 | 165.25M |
December 31, 2012 | 177.18M |
September 30, 2012 | 182.21M |
June 30, 2012 | 170.66M |
March 31, 2012 | 213.85M |
December 31, 2011 | 210.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
277.27M
Minimum
Sep 2019
1.535B
Maximum
Dec 2023
949.48M
Average
929.78M
Median
Shareholders Equity (Quarterly) Benchmarks
Genmab A/S | 4.701B |
Ascendis Pharma A/S | -257.21M |
Galecto Inc | 28.16M |
Evaxion Biotech AS | -4.739M |
IO Biotech Inc | 115.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.970B |
Total Liabilities (Quarterly) | 498.58M |
Debt to Equity Ratio | 0.0016 |
Current Ratio | 1.641 |
Net Debt Paydown Yield | 2.55% |